DEA Issues Rules for Providing Medication-Assisted Drug Dependence Treatment Under SUPPORT Act

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson Controlled Substances Module, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

DEA Issues Rules for Providing Medication-Assisted Drug Dependence Treatment Under SUPPORT Act

Staff Writers

November 15, 2020 at 22:25:58 ET

The DEA has published an interim final rule implementing provisions of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018 (SUPPORT Act) (85 Fed. Reg. 69153, Nov. 2, 2020). The statute, Pub. L. No. 115-271, amended the Controlled Substances Act (CSA) by expanding the options through which a physician may qualify... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

DEA Issues Rules for Providing Medication-Assisted Drug Dependence Treatment Under SUPPORT Act

My Research Folders

THOMPSON CONTROLLED SUBSTANCES

COMPLIANCE EXPERT

DEA RESOURCES

HELP

CONTACT